In vivo lipoprotein lipase-mediated triglyceride metabolism in the human heart (vol 54, pg S49, 2006)

被引：0

|

作者：

Carmel, CA

机构：

来源：

JOURNAL OF INVESTIGATIVE MEDICINE | 2006年 / 54卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：100 / 100

页数：1

相关论文

共 7 条

[1] In vivo lipoprotein lipase-mediated triglyceride metabolism in the human heart
Miles, J. M.
Nelson, R. H.
Prasad, A.
Lerman, A.
DIABETOLOGIA, 2006, 49 : 42 - 43
[2] Lipoprotein lipase-mediated triglyceride metabolism in the human heart
Miles, John M.
Nelson, Robert H.
Prasad, Abhiram
Lerman, Amir
DIABETES, 2006, 55 : A341 - A341
[3] Apolipoprotein CIII is a potent inhibitor of lipoprotein lipase-mediated triglyceride hydrolysis in vivo.
Rensen, PC
Jong, MC
Dahlmans, VE
Van der Boom, H
Van Berkel, TJ
Havekes, LM
CIRCULATION, 2001, 104 (17) : 268 - 268
[4] Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo
Rensen, PCN
vanBerkel, TJC
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (25) : 14791 - 14799
[5] 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (vol 129, pg S49, 2014)
Goff
CIRCULATION, 2014, 129 (25) : S74 - S75
[6] Kruppel-like factor 14 inhibits atherosclerosis via mir-27a-mediated down-regulation of lipoprotein lipase expression in vivo (vol 289, pg 143, 2019)
Xie, Wei
Li, Liang
Gong, Duo
Zhang, Min
Lv, Yun-Cheng
Guo, Dong-ming
Zhao, Zhen-Wang
Zheng, Xi-Long
Zhang, Da-Wei
Dai, Xiao-Yan
Yin, Wei-Dong
Tang, Chao-Ke
ATHEROSCLEROSIS, 2021, 331 : 56 - 57
[7] Genotype of galectin 2 (LGALS2) is associated with insulin-glucose profile in the British Women's Heart and Health Study (vol 49, pg 2815, 2006)
Christensen, M. B.
Lawlor, D. A.
Gaunt, T. R.
Howell, W. M.
Smith, G. Davey
Ebrahim, S.
Day, I. N. M.
DIABETOLOGIA, 2006, 49 (11) : 2815 - 2815